UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors

Haematologica (Roma), 2012-05, Vol.97 (5), p.723-730

2012

Volltextzugriff (PDF)

Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

Bone marrow transplantation (Basingstoke), 2020-03, Vol.55 (3), p.633-640

2020

Volltextzugriff (PDF)

CONSOLIDATIVE HCT‐ASCT IS SUPERIOR TO NON‐MYELOABLATIVE CHEMO‐IMMUNOTHERAPY IN NEWLY‐DIAGNOSED PCNSL ‐ UPDATED RESULTS OF THE RANDOMIZED PHASE III MATRIX/IELSG43 TRIAL

Hematological oncology, 2023-06, Vol.41 (S2), p.41-43

2023

Volltextzugriff (PDF)

Long-term follow-up of patients with relapsed or refractory non-Hodgkin's lymphoma receiving allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2016-11, Vol.51 (11), p.1527-1529

2016

Volltextzugriff (PDF)

Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML—long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)

Annals of oncology, 2015-07, Vol.26 (7), p.1434-1440

2015

Volltextzugriff (PDF)

INTENSIVE IMMUNOCHEMOTHERAPY (R‐CHOEP) VS HIGH‐DOSE IMMUNOCHEMOTHERAPY (R‐MegaCHOEP) IN YOUNG PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA: A 10‐YEAR LONG‐TERM FOLLOW‐UP

Hematological oncology, 2019-06, Vol.37 (S2), p.431-432

2019

Volltextzugriff (PDF)

FIRST‐LINE THERAPY OF T‐CELL LYMPHOMA: ALLOGENEIC OR AUTOLOGOUS TRANSPLANTATION FOR CONSOLIDATION ‐ FINAL RESULTS OF THE AATT STUDY

Hematological oncology, 2019-06, Vol.37 (S2), p.99-101

2019

Volltextzugriff (PDF)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO‐HSCT) FOR PATIENTS WITH RELAPSED/REFRACTORY SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA (R/R SALCL). A RETROSPECTIVE ANALYSIS OF THE LYMPHOMA WORKING PARTY‐EBMT

Hematological oncology, 2017-06, Vol.35 (S2), p.242-243

2017

Volltextzugriff (PDF)

Topic: AS01-Diagnosis/AS01b-Flow cytometry: FLOW CYTOMETRIC SCREENING IN PERIPHERAL BLOOD TO GUIDE THE DIAGNOSTIC ALGORITHM IN MDS

Leukemia research, 2023-05, Vol.128, p.107140, Article 107140

2023

Volltextzugriff (PDF)

Reply to: 'Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity' by Kern et al

Leukemia, 2011-05, Vol.25 (5), p.895-897

2011

Volltextzugriff (PDF)

9431 POSTER Whole-body-PET/MRI a New Way of Imaging in Soft Tissue Sarcomas

European journal of cancer (1990), 2011, Vol.47, p.S671-S672

2011

Volltextzugriff (PDF)

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment

Leukemia research, 2021-09, Vol.108, p.106681, Article 106681.43

2021

Volltextzugriff (PDF)

P44 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: PROGNOSTIC SIGNIFICANCE OF HISTOLOGICAL BLAST COUNT IN MYELODYSPLASTIC SYNDROMES

Leukemia research, 2021-09, Vol.108

2021

Volltextzugriff (PDF)

Pulmonary adverse events in unrelated donors of peripheral blood stem cells

Transfusion medicine (Oxford, England), 2013-02, Vol.23 (1), p.69-71

2013

Volltextzugriff (PDF)

Dose-reduced conditioning for allogeneic blood stem cell transplantation : durable engraftment without antithymocyte globulin

Bone marrow transplantation (Basingstoke), 2000-07, Vol.26 (2), p.119-125

2000

Volltextzugriff (PDF)

Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life‐threatening vincristine neurotoxicity

British journal of haematology, 2001-11, Vol.115 (2), p.323-325

2001

Volltextzugriff (PDF)

Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

Journal of clinical oncology, 2003-12, Vol.21 (24), p.4489-4495

2003

Volltextzugriff (PDF)

Pelvic magnetic resonance imaging after bone marrow harvest - a retrospective study in 50 unrelated marrow donors

Bone marrow transplantation (Basingstoke), 2005-04, Vol.35 (7), p.667-673

2005

Volltextzugriff (PDF)

Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation

British journal of haematology, 2001-09, Vol.114 (4), p.944-950

2001

Volltextzugriff (PDF)

26 Collection of peripheral blood stem cells in allogeneic donors via femoral venous lines - safe, successful and well-tolerated

Transfusion and apheresis science, 2010, Vol.43 (1), p.S6-S6

2010

Volltextzugriff (PDF)

Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse

Cancer management and research, 2022, Vol.14, p.547-559

2022

Volltextzugriff (PDF)

Long-term follow-up of patients with relapsed or refractory non-Hodgkin%apos;s lymphoma receiving allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2016-11, Vol.51 (11), p.1527

2016

Volltextzugriff (PDF)

Cup-like acute myeloid leukemia: new disease or artificial phenomenon?

Haematologica (Roma), 2008-02, Vol.93 (2), p.283-286

2008

Volltextzugriff (PDF)

Leukemia cutis, chloroma or suspender-induced dermatosis?

Haematologica (Roma), 2001-02, Vol.86 (2), p.224

2001

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

KollektionSpringer Journals

PublikationsformBerichte

ThemaHematopoietic Stem Cell Transplantation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(38)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(19)
Adult
(16)
Male
(16)
Female
(14)
Hematology
(14)
Middle Aged
(14)
Transplantation
(11)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Oncology
(10)
Aged
(7)
Lymphoma
(7)
Stem Cell Transplantation
(7)
Hematologic And Hematopoietic Diseases
(6)
Stem Cells
(6)
Immunology
(5)
Prognosis
(5)
Treatment Outcome
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors

Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation

CONSOLIDATIVE HCT‐ASCT IS SUPERIOR TO NON‐MYELOABLATIVE CHEMO‐IMMUNOTHERAPY IN NEWLY‐DIAGNOSED PCNSL ‐ UPDATED RESULTS OF THE RANDOMIZED PHASE III MATRIX/IELSG43 TRIAL

Long-term follow-up of patients with relapsed or refractory non-Hodgkin's lymphoma receiving allogeneic stem cell transplantation

Mito-FLAG with Ara-C as bolus versus continuous infusion in recurrent or refractory AML—long-term results of a prospective randomized intergroup study of the East German Study Group Hematology/Oncology (OSHO) and the Study Alliance Leukemia (SAL)

INTENSIVE IMMUNOCHEMOTHERAPY (R‐CHOEP) VS HIGH‐DOSE IMMUNOCHEMOTHERAPY (R‐MegaCHOEP) IN YOUNG PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA: A 10‐YEAR LONG‐TERM FOLLOW‐UP

FIRST‐LINE THERAPY OF T‐CELL LYMPHOMA: ALLOGENEIC OR AUTOLOGOUS TRANSPLANTATION FOR CONSOLIDATION ‐ FINAL RESULTS OF THE AATT STUDY

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO‐HSCT) FOR PATIENTS WITH RELAPSED/REFRACTORY SYSTEMIC ANAPLASTIC LARGE CELL LYMPHOMA (R/R SALCL). A RETROSPECTIVE ANALYSIS OF THE LYMPHOMA WORKING PARTY‐EBMT

Topic: AS01-Diagnosis/AS01b-Flow cytometry: FLOW CYTOMETRIC SCREENING IN PERIPHERAL BLOOD TO GUIDE THE DIAGNOSTIC ALGORITHM IN MDS

Reply to: 'Flow cytometric identification of acute myeloid leukemia with limited differentiation and NPM1 type A mutation: a new biologically defined entity' by Kern et al

9431 POSTER Whole-body-PET/MRI a New Way of Imaging in Soft Tissue Sarcomas

Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment

P44 - Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: PROGNOSTIC SIGNIFICANCE OF HISTOLOGICAL BLAST COUNT IN MYELODYSPLASTIC SYNDROMES

Pulmonary adverse events in unrelated donors of peripheral blood stem cells

Dose-reduced conditioning for allogeneic blood stem cell transplantation : durable engraftment without antithymocyte globulin

Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life‐threatening vincristine neurotoxicity

Primary Central Nervous System Lymphoma: Results of a Pilot and Phase II Study of Systemic and Intraventricular Chemotherapy With Deferred Radiotherapy

High‐dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL‐GITMO

Pelvic magnetic resonance imaging after bone marrow harvest - a retrospective study in 50 unrelated marrow donors

Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation

26 Collection of peripheral blood stem cells in allogeneic donors via femoral venous lines - safe, successful and well-tolerated

Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse

Long-term follow-up of patients with relapsed or refractory non-Hodgkin%apos;s lymphoma receiving allogeneic stem cell transplantation

Cup-like acute myeloid leukemia: new disease or artificial phenomenon?

Leukemia cutis, chloroma or suspender-induced dermatosis?

Aktive Filter

Suchergebnisse filtern